IP Library Granted Patent US 11,406,695
Granted Patent B2
US 11,406,695 · App. 16/894,968 · Granted Aug 9, 2022

Recombinant expression of

Inventors: Lan Zhang (Chalfont, PA); Zhiyun Wen (Devon, PA); Craig T. Przysiecki (Kintnersville, PA); Ping Qiu (Cranbury, NJ)
Assignee: Merck Sharp & Dohme LLC
A61K39/02A61P31/04C07K14/295C12N15/70A61K2039/54A61K2039/55511
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,406,695
App. No.
16/894,968
Granted
Aug 9, 2022
Kind
B2
Abstract

The present invention relates to methods for the recombinant expression of chlamydia major outer membrane protein (MOMP) comprising transforming a population of E. coli host cells with an expression vector comprising a nucleic acid molecule that encodes chlamydia MOMP and encodes a leader sequence for targeting the MOMP to the outer membrane of the cell, wherein the nucleic acid molecule is operatively linked to a promoter. The method of the invention allows expression of MOMP in the outer membrane of the cell, which leads to protein folding that is more like native MOMP relative to a MOMP protein that is expressed intracellularly. Also provided by the invention are uses of the recombinant MOMP in pharmaceutical compositions and methods for the treatment and/or prophylaxis of chlamydia infection and/or the effects thereof.

Claims (9)

1. A nucleic acid molecule comprising a sequence of nucleotides as set forth in SEQ ID NO:15, SEQ ID NO:18, or SEQ ID NO:21.

2. The nucleic acid molecule of claim 1 , comprising a sequence of nucleotides as set forth in SEQ ID NO:15.

3. The nucleic acid molecule of claim 1 , comprising a sequence of nucleotides as set forth in SEQ ID NO:18.

4. The nucleic acid molecule of claim 1 , comprising a sequence of nucleotides as set forth in SEQ ID NO:21.

5. A nucleic acid molecule comprising a nucleic acid derivative having at least 85% sequence identity to a sequence of nucleotides set forth in SEQ ID NO 15, SEQ ID NO: 18, or SEQ ID NO: 21, wherein the nucleic acid molecule retains the leader sequence.

6. A nucleic acid molecule comprising a nucleic acid derivative having at least 90% sequence identity to a sequence of nucleotides set forth in SEQ ID NO 15, SEQ ID NO: 18, or SEQ ID NO: 21, wherein the nucleic acid molecule retains the leader sequence.

7. A nucleic acid molecule comprising a nucleic acid derivative having at least 95% sequence identity to a sequence of nucleotides set forth in SEQ ID NO 15, SEQ ID NO: 18, or SEQ ID NO: 21, wherein the nucleic acid molecule retains the leader sequence.

8. A nucleic acid molecule comprising a nucleic acid derivative having at least 97% sequence identity to a sequence of nucleotides set forth in SEQ ID NO 15, SEQ ID NO: 18, or SEQ ID NO: 21, wherein the nucleic acid molecule retains the leader sequence.

9. A nucleic acid molecule comprising a nucleic acid derivative having at least 99% sequence identity to a sequence of nucleotides set forth in SEQ ID NO 15, SEQ ID NO: 18, or SEQ ID NO: 21, wherein the nucleic acid molecule retains the leader sequence.

Assignments (3)
MERGER Recorded May 19, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 059956/0784 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2020
From: WEN, ZHIYUN
To: MERCK SHARP & DOHME CORP.
Reel/Frame 052889/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2020
From: ZHANG, LAN; PRZYSIECKI, CRAIG T.; KHANDELWAL, PUNEET; QIU, PING
To: MERCK SHARP & DOHME CORP.
Reel/Frame 052862/0259 →
Continuity (3)
Division 15527789
Provisional Application 62082889 · Nov 21, 2014
Related Publication 20210093703A1 · Apr 1, 2021